Ikarian Capital
Venture capitalDallas · Pre-Seed–Late Stage
Also known as IKARIAN CAPITAL, LLC
Investment thesis
Ikarian Capital invests in biotech companies advancing drug discovery and development, led by a team with scientific and biotech-specific finance expertise. It selects companies pursuing cutting-edge science with sound business fundamentals across the spectrum of early- to late-stage clinical trials, remaining agnostic to indication, market cap, and geography. The firm deploys transformational, long-term capital to support emerging companies as they progress through the clinic. It emphasizes a selective, contrarian approach backed by a proprietary process aligned with the team's core expertise, and is committed to building an enduring business with strong values and high ethical standards.
Source: firm website, verified Sep 1, 2026.
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2Enterprise Software ×1Fintech ×1PropTech ×1
HQs:United States×2New Zealand×1
Investments · 3 tracked
founders shown can be your intro pathJasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases.
BiotechHealthtechRedwood City, US
Judith Shizuru(Director)Herb Cross(Executive Officer)inJeet Mahal(Executive Officer, Director)inPatrick Crutcher(Director)Svetlana Lucas(Director)Wenru Song(Executive Officer)
Co-investorsAvego BioScience CapitalTSVCAbingworth
Jasper is a commercial real estate fund management firm that deploys and manages capital for institutional investors into industrial, logistics, and other asset classes across Australia and New Zealand.
Enterprise SoftwareFintechPropTechAuckland, NZ
Mark Campbell(CEO and Executive Director)in
Co-investorsBlackstoneArc AngelsIcehouse VenturesBessemer Venture PartnersCoatue ManagementFoundation Capital+4 more
Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases.
BiotechHealthtechCambridge, US
Wenru Song(Founder)in
Co-investorsForesite CapitalQuan CapitalVivo Capital
Exits · 1
IPOs and acquisitions across the tracked portfolioJasper TherapeuticsNASDAQ: JSPR
Portfolio news
latest coverage across their companiesJasper · investing.com · Aug 18, 2026
Jasper Therapeutics · investing.com · Aug 18, 2026
Kira Pharmaceuticals · blockonomi.com · Aug 14, 2026
Frequently asked questions
- What stage does Ikarian Capital invest at?
- Ikarian Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Ikarian Capital focus on?
- Ikarian Capital focuses on Biotech.
- Where is Ikarian Capital located?
- Ikarian Capital is headquartered in Dallas, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.